Invitrogen and Agilent settle patent suits.Carlsbad and Santa Clara, CA 2/5/08 -- Invitrogen and Agilent have reached a confidential agreement to settle three lawsuits. Stratagene, which Agilent acquired last year (see IBO Ibo: see Igbo. 4/15/07), was a party in all three suits. Under the agreement, Agilent will make a payment to Invitrogen for an undisclosed amount and discontinue sales of RNase H minus reverse transcriptase Reverse transcriptase
Any of the deoxyribonucleic acid (DNA) polymerases present in particles of retroviruses which are able to carry out DNA synthesis using an RNA template. products. This agreement stems from a 2000 suit filed by Invitrogen against Stratagene for infringement of three patents related to RNase H minus reverse transcriptase products (US Patent Nos. 6,063,608; 5,244,797; 5,405,776). In addition, under the settlement, Invitrogen will obtain a license to Agilent's DNA polymerase DNA polymerase /DNA po·lym·er·ase/ (pah-lim´er-as) any of various enzymes catalyzing the template-directed incorporation of deoxyribonucleotides into a DNA chain, particularly one using a DNA template. blend products and pay a royalty fee. In 2001, Stratagene sued Invitrogen for infringement of its patent related to the sale of certain DNA polymerase blend products (US Patent No. 5,556,772). The third suit was Invitrogen's 2001 action against Stratagene for infringement of a patent covering a process for producing E. coli cells for more effectively absorbing foreign DNA DNA: see nucleic acid.
or deoxyribonucleic acid
One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. (US Patent No. 4,981,797), for which Invitrogen was awarded $16.2 million and additional fees in a 2006 trial (see IBO 11/15/06).
The suit involving US Patent No. 4,981,797 was under appeal. Following the acquisition of Stratagene, Agilent has acted quickly to settle the acquired company's litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.
When a person begins a civil lawsuit, the person enters into a process called litigation. , which also included a dispute with Applied Biosystems (see IBO 9/30/07).